 |
| Interventional Neurology Market |
A) Market Overview:
The global Interventional Neurology Market is estimated to be valued at
US$2,450.6 million in 2022 and is expected to exhibit a CAGR of 5.3% over the
forecast period of 2022-2030. Interventional neurology involves minimally
invasive procedures to treat neurological disorders, such as stroke, aneurysms,
and arteriovenous malformations. These procedures offer several advantages,
including shorter hospital stays, reduced recovery time, and improved patient
outcomes. The increasing prevalence of neurological diseases and the need for
effective treatment options are driving the demand for interventional neurology
products globally.
B) Market Key Trends:
One key trend in the Interventional
Neurology Market Size is the rise in demand for neurovascular devices.
Neurovascular devices are crucial in the diagnosis and treatment of various
neurological conditions. For instance, the demand for clot retrieval devices
used in the treatment of acute ischemic strokes is on the rise. These devices
help remove blood clots from the brain, restoring blood flow and minimizing
long-term damage. The market is witnessing advancements in technologies, such
as the development of stent retrievers and aspiration catheters, which enable
efficient clot extraction.
An example of supporting this trend is the Solitaire™ Revascularization Device
developed by Medtronic. It is a highly effective clot retrieval device that has
shown improved outcomes in clinical trials. The device enables rapid
restoration of blood flow, minimizing neurological damage and improving patient
outcomes. The increasing adoption of such advanced neurovascular devices is
significantly contributing to the growth of the market.
C) Porter's Analysis:
- Threat of New Entrants: The high entry barriers due to strict regulatory
requirements and the need for substantial investments in research and
development act as deterrents for new entrants.
- Bargaining Power of Buyers: The demand for interventional neurology products
is increasing, giving buyers the advantage of choice and negotiation. However,
the critical nature of these products allows suppliers to maintain a certain
level of bargaining power.
- Bargaining Power of Suppliers: The market is dominated by established players
with a strong supplier base. This gives suppliers significant bargaining power
in terms of pricing and product quality.
- Threat of New Substitutes: The market is witnessing advancements in
alternative treatment methods, such as telemedicine-based interventions.
However, these substitutes are not yet considered as effective as traditional
interventional neurology procedures.
- Competitive Rivalry: The market is highly competitive, with key players
constantly investing in research and development to introduce innovative
products. The presence of established players and high market consolidation
contribute to intense competition.
D) Key Takeaways:
Market size: The global Interventional Neurology Market is expected to witness
high growth, exhibiting a CAGR of 5.3% over the forecast period. This growth
can be attributed to the increasing prevalence of neurological disorders,
coupled with advancements in interventional neurology technologies.
Regional analysis: North America is currently the fastest-growing and
dominating region in the Interventional Neurology Market. This can be
attributed to factors such as the presence of key market players, favorable
reimbursement policies, and a high prevalence of neurological disorders in the
region.
Key players: Key players operating in the global Interventional Neurology
Market include Penumbra, Inc., Medtronic, Stryker, Terumo Corporation, Johnson
& Johnson Services, Inc., Boston Scientific Corporation, MicroPort
Scientific Corporation, Merit Medical Systems, W. L. Gore & Associates,
Inc., Abbott, Cook, and Palex Medical. These companies focus on product
innovation, partnerships, and acquisitions to strengthen their market position.
In conclusion, the Interventional Neurology Market is witnessing significant
growth due to the increasing demand for neurovascular devices and advancements
in treatment options. The market is highly competitive, with key players
constantly striving to introduce innovative products. North America is
currently the leading market in terms of growth and dominance. With the rise in
neurological disorders worldwide, the demand for interventional neurology
products is only expected to increase in the coming years.
